Adequacy of dialysis in the acute renal failure of the critically ill: The case for continuous therapies

International Journal of Artificial Organs

Volumn 19, Issue 2, 1996, Pages 129-142

  Bellomo, Rinaldo ^a   Ronco, C ^b  

^a AUSTIN HOSPITAL   (Australia)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CRITICALLY ILLS; RENAL FAILURE;

ACUTE KIDNEY FAILURE; CRITICAL ILLNESS; HEMODIALYSIS; HUMAN; REVIEW;

EID: 0029870192     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889601900217     Document Type: Review

References (190)

1. Vanholder RC, Ringoir SM. Adequacy of dialysis: A critical analysis. Kidney Int 1992; 42: 540-58.
2. Hakim R. Assessing the adequacy of dialysis. Kidney Int 1990; 37: 822-32.
3. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity. Report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305: 1176-81.
4. Lowrie EG, Laird NM, (eds). Cooperative Dialysis Study. Kidney Int 1983; 23 (Suppl 13): S1-122.
5. Gotch FA, Krueger KK, (eds). Adequacy of dialysis. Kidney Int 1975; 7 (Suppl 2): S1-263.
6. Depner TA. Assessing adequacy of hemodialysis: Urea modeling. Kidney Int 1994; 45: 1522-35.
7. Owen WF, Lew NL, Lui Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-6.
8. Depner TA. Pitfalls in quantitating hemodialysis. Semin Dial 1993; 6: 127-33.
9. Laird NM, Berkey CS, Lowrie EG. Modeling success or failure of dialysis therapy: the National Cooperative Dialysis Study. Kidney Int 1983; 23 (Suppl 13): S101-S106.
10. Hakim R, Depner TA, Parker TF. In-depth review: adequacy of hemodialysis. Am J Kidney Dis 1992; 20: 107-23.
11. Teschan PE, Ginn HE, Bourne JR, et al. Quantitative indices of clinical uremia. Kidney Int 1979; 15: 676-97.
12. Bourne JR, Teschan PE. Computer methods, uremic encephalopathy and adequacy of dialysis. Kidney Int 1983; 24: 496-506.
13. Lewis EG, O'Neill WM, Dustman RE, Beck EC. Temporal effects of hemodialysis on measures of neural efficiency. Kidney Int 1980; 17: 357-63.
14. Gilli P, De Bastiani P. Cognitive function and regular dialysis treatment. Clin Nephrol 1983; 19: 188-92.
15. Marsh JT, Brown WS, Wolcott D, Laudsverk J, Niessenson R. Electrophysiological indices of CNS function in hemodialysis and CAPD. Kidney Int 1986; 30: 957-63.
16. Lindsay RM, Henderson LW. Adequacy of dialysis. Kidney Int 1988; 33 (Suppl 24): S92-9.
17. Blake PG, Sombolos K, Abraham G, et al. Lack of correlation between urea kinetic indices and clinical outcome in CAPD patients. Kidney Int 1991; 39: 700-6.
18. Fuerst P, Zimmerman L, Bergstroem J. Determination of endogenous middle molecules in normal and uremic body fluids. Clin Nephrol 1976; 5: 178-87.
19. Luke RG. Uremia and the BUN. N Engl J Med 1981; 305: 1213-5.
20. Schoots A, Mikkers F, Cramers C, de Smet R, Ringoirs S. Uremic toxins and the elusive middle molecules. Nephron 1984; 38: 1-8.
21. Ritz E, Deppisch R, Nawroth P. Toxicity of ureamia does it come of AGE? Nephrol Dial Transplant 1994; 9: 1-2.
22. Hoerl WH, Heidland A. Evidence for the participation of granulocyte proteinases on intradialytic catabolism. Clin Nephrol 1984; 21: 314-22.
23. Parker TF, Husni L, Huang W, Lew N, Lowrie EG, and Dallas Nephrology Associates. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kid Dis 1994; 23: 670-80.
24. Collins AJ, Ma JM, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis patient survival. Am J Kid Dis 1994; 23: 272-82
25. Hakim R, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kid Dis 1994; 23: 661-9.
26. Linsay R, Heidenheim AP, Spanner E, Kortas C, Blake PG. Adequacy of hemodialysis and nutrition - important determinants of morbidity and mortality. Kidney Int 1994; 45: 385-91.
27. Ronco C, Burchardi H. Management of acute renal failure in the critically ill patient. In: Pinsky MR, Dhainaut JFA, eds. Pathophysiobiologic Foundations of Critical Care. Williams and Wilkins Baltimore 1993.
28. Swartz RD, Valk TW, Brain AJP, Hsu CH. Complications of hemodialysis and peritoneal dialysis in acute renal failure. Trans Am Soc Artif Intern Organs 1980 3: 98-101.
29. Vas SQ. Peritonitis. In: Norph KD, ed. Peritoneal dialysis 2nd ed. Boston: Martinus Nijhoff, 1985.
30. Korchik UP, Brown DC, De Master EG. Hemodialysis induced hypotension. Int J Artif Organs 1978; 1: 151-5.
31. Kjellstrand CM, Rosa AA, Shidemann JR. Hypotension during hemodialysis: osmolatity fall is an important pathogenic factor. Trans Am Soc Artif Intern Organs 1980; 3: 11-4.
32. Johnson NR, Bischel MD, Boylen CT, Mohler JG. Hypoxemia and hyperventilation in chronic hemodialysis. Clin Res 1970; 19: 145-9.
33. Bischel MD, Scoles BG, Mohler JG. Evidence for pulmonary microembolization during hemodialysis. Chest 1975; 67: 335-7.
34. Bischel MD, Orrell FL, Scoles BG, Mohler JG, Barbour BH. Effects of microemboli blood filtration during hemodialysis. Trans Am Soc Artif Intern Organs 1973; 19: 492-7.
35. Kaplow LS, Foffinet JA. Profound neutropenia during the early phase of hemodialysis. JAMA 1968; 203: 1135-7.
36. Chenoweth DE, Cheung AK, Henderson LW. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Kidney Int 1983; 24: 764-9.
37. Hakim RM, Lowrie EG. Hemodialysis associated neutropenia hypoxemia: the effect of dialyzer membrane materials. Nephron 1982; 32: 32-9.
38. Mault JR, Dechert RE, Bartlett RH, Swartz RD, Ferguson SK. Oxygen consumption during hemodialysis for acute renal failure. Trans Am Soc Artif Intern Organs 1982; 28: 510-3.
39. Carlon GC, Campfieid PB, Goldiner PL, Turnbull AD. Hypoxemia during hemodialysis. Crit Care Med 1979; 7: 497-501.
40. Endou K, Kamijima J, Kakubari Y, Kirkawada R. Hemodynamic changes during dialysis. Cardiology 1978; 63: 175-87.
41. Von Hartizch B, Eaton JW, Buselmeier TJ, Kjellstrand CM. Dialysis disequilibrium: a manifestation of impaired tissue oxygenation Trans Am Soc Artif Intern Organs 1974; 20: 373-7.
42. Manns M, Sigler MH, Teehan BP, Frees R, Dixit K. Effects of intermittent hemodialysis on residual renal function in critically ill patients with acute renal failure. (Abstract) Int J Artif Organs 1994; 17: 442.
43. Dieber L, Kozol R, Wilson RF, Mahajan S, Abu-Hamdan D, Thomas D. Gastric intramucosal acidosis in patients with chronic kidney failure. Surgery 1993; 113: 520-6.
44. Smit JC, Gareth Jones J. Oxygen saturation during hemodialysis. Ren. Fail 1993; 15: 239-45.
45. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in haemodialysis. N Engl J Med 1977; 296: 769-74.
46. Aunsholt NA, Larsen C. The arterial oxygen extraction tension and oxygen compensation factor during acetate and bicarbonate dialysis. Blood Purif 10: 1992; 317-25.
47. Bouffard Y, Viale J-P, Annat G, et al. Pulmonary gas exchange during hemodialysis. Kidney Int 1986; 30: 920-3.
48. Romaldini H, Rodriguez-Roisin R, Lopez FA, Ziegler TW, Bencowitz HZ, Wagner PD. The mechanisms of arterial hypoxemia during hemodialysis. Am Rev Respir Dis 1984; 129: 780-4.
49. Patterson RW, Nissenson AR, Miller J, Smith RT, Narins RG, Sullivan SF. Hypoxemia and pulmonary gas exchange during hemodialysis. J Appl Physiol 1981; 50: 259-64.
50. Kirkendol PL, Pearson JE, Bower JD, Holbert RD. Myocardial depressant effects of sodium acetate. Cardiovasc Res 1978; 12: 127-36.
51. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990; 38: 487-94.
52. Luger A, Kovarik J, Stummvoll H-K, Urbanska A, Luger TA. Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 1987; 32: 84-8.
53. Lien J, Chan V. Risk factors influencing survival in acute renal failure treated by hemodialysis. Arch Intern Med 1985; 145: 2067-9.
54. Groeneveld ABJ, Tran DD, van der Meulen J, Nauta JJP, Thijs JG. Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. Nephron 1991; 59: 602-10.
55. Wheeler DC, Feehally J, Walls J. High risk acute renal failure. Q J Med 1986; 61: 977-84.
56. Lange HW, Aeppli DM, Brown DC. Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators. Am Heart J 1987; 113: 1138-43.
57. Spiegel DM, Ullian ME, Zerbe GO, Berl T. Determinants of survival and recovery in acute renal failure patients dialysed in intensive care unit. Am J Nephrol 1991; 11: 44-7.
58. Chew SL, Lins RL, Daelemans R, De Boer ME. Outcome in acute renal failure. Nephrol Dial Transplant 1993; 8: 101-7.
59. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F. Arteriovenous hemofiltration: a new and simple method for treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 1977; 55: 1121-2.
60. Geronemus R, Schneider N. Continuous arteriovenous hemodialysis: a new modality for treatment of acute renal failure. Trans Am Soc Artif Intern Organs 1984; 30: 610-3.
61. Bellomo R, Parkin G, Love J, Boyce N. Management of acute renal failure in the critically ill with continuous venovenous hemodiafiltration. Ren Fail 1992; 14: 183-6.
62. Wendon J, Smithies M, Sheppard A, Bullenk Tinker J, Bihari D. Continuous high-volume veno-venous hemofiltration in acute renal failure. Intensive Care Med 1989; 15: 358-63.
63. Mc Donald BR, Mehta RL. Decreased mortality in patients with acute renal failure undergoing continuous arteriovenous hemodialysis. Contrib Nephrol 1991; 93: 51-6.
64. Hakim RM. Clinical implications of hemodialysis membrane biocompatibiliy. Kidney Int 1993; 44: 484-94.
65. Schiffe H, Lang SM, Koenig A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344: 570-2.
66. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-29.
67. Knaus WA, Wagner DA, Draper EA, et al. The APACHE III Prognostic system. Risk predictions of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-36.
68. Le Gall J-R Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter Study. JAMA 1993; 270: 2957-63.
69. Lemeshaw S, Teres D, Klar J, Spitz Avrunin J, Gehlbach SH, Rapoport J. Mortality probability models (MPM II) based on an international cohort of intensive Care Unit patients. JAMA 1993; 270: 2478-86.
70. The ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
71. Europeen Society of Intensive Care Medicine Expert Panel. The use of the pulmonary artery catheter. Intensive Care Med 1991; 17: I-VIII.
72. Bidani A, Tzounakis AE, Cardenas VJ, Zwischenberger JB. Permissive hypercapnia in acute respiratory failure. JAMA 1994 272: 957-62.
73. Slutsky AS. Consensus conferencence on mechanical ventilation. Part I. Intensive Care Med 1994; 20: 64-79.
74. Slutsky AS. Consensus conference on mechanical ventilation. Part II. intensive Care Med 1994; 20: 150-62.
75. Gattinoni L, Feriani M. Acid-base derangements in acute renal failure. In: Pinsky MR, Dhainaut J-FA, eds. Pathophysiologic Foundations of Critical Care. Williams & Wilkins, Baltimore 1993.
76. Kveim M, Nesbakken R. Utilization of exogenous acetate during hemodialysis. Trans Am Soc Artif Int Organs 1975; 21: 138-42.
77. Bouffard Y, Viale JP, Annat G, et al. Pulmonary gas exchange during hemodialysis. Kidney Int 1986; 30: 920-7.
78. 2 in metabolism of acetate as an explanation for hypoventilation and hypoxemia during hemodialysis. Proc Clin Dial Transpl Forum 1970; 9: 226-31.
79. Kirschbaum B, Galishoff M, Reines HD. Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation. Crit Care Med 1993; 20: 349-53.
80. Barton IK, Streather CP, Hilton PJ, Bradley RD. Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid. Nephrol Dial Transplant 1991; 6: 368-70.
81. Davenport A, Will EJ, Davison AM. Paradoxical increase in arterial hydrogen ion concentration in patients with hepatorenal failure given lactate-based fluids. Nephrol Dial Transplant 1990; 5: 342-6.
82. Nimmo G, Grant IS, Mackenzie SJ. Lactate and acid base changes in the critically ill. Postgrad Med J Suppl 1991; 1: 556-61.
83. Nimmo GR, Mackenzie SJ, Walker S, Nicol M, Grant IS. Acid-base response to high volume haemofiltration in the critically ill. Nephrol Dial Transplant 1993; 8: 854-7.
84. Bocci V. Interleukins: Clinical Pharmacokinetics and practical implications. Clin Pharmacokinet 1991; 21: 274-84.
85. Pessina GP, Pacini A, Bocci V, Maioli E, Naldini A. Studies on tumor necrosis factor (TNF): II Metabolic fate and distribution of human recombinant TNF. Lymphokine Res 1987; 6: 35-43.
86. Klapproth J, Castell J, Geigh T, Andaus T, Heinrich PC. Fate and biological action of human recombinant interleukin I beta in the rat in vivo. Eur J Immunol 1989; 19: 1485-90.
87. Howdieshell TR, Blalock WE, Bowen PA, Hawkins ML, Hess C. Management of post-traumatic acute renal failure with peritoneal dialysis. Am Surg 1992; 58: 378-82.
88. Stevens PE, Davies SP, Brown EA, Riley B, Gower PE, Kox W. Continuous arteriovenous hemodialysis in critically ill patients. Lancet 1988; 2: 150-2.
89. Pattison ML, Lee SM, Ogden DA. Continuous arteriovenous hemodiafiltration: an aggressive approach to the management of acute renal failure. Am J Kid Dis 1988; 11: 43-7.
90. Voerman HJ, Strack van Schijndel RJM, Thijs LG. Continuous arteriovenous hemodiafiltration in critically ill patients. Crit Care Med 1994; 18: 911-4.
91. Reynolds HM, Borg U, Beizberg H, Wiles CE. Efficacy of continuous arteriovenous hemofiltration with dialysis in patients with renal failure. Crit Care Med 1991; 19: 1387-94.
92. Conand B, Garved LJ, Christol JP, Aubas S, Berand JJ, Mion C. Pump assisted continuous veno-venous hemofiltration for treating acute uremia. Kidney Int 1988; 33 (suppl 24): 5154-6.
93. Bellomo R, Ernest D, Love J, Parkin G, Boyce N. Continuous arteriovenous hemodiafiltration: an optimal therapy for acute renal failure in an intensive care setting. Aust NZ J Med 1990; 20: 237-42.
94. Bellomo R, Parkin G, Love J, Boyce N. Management of acute renal failure in the critically ill with continuous veno-venous hemodiafiltration. Ren Fail 1992; 14: 183-6.
95. Schaefer GE, Dolring C, Sodemann K, Russ A, Schroeder HM. Continuous arteriovenous and venovenous hemodialysis in critically ill patients. Contrib Nephrol 1991; 93: 23-8.
96. Humphrey H, Hall J, Sznajder I. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990; 97: 1176-80.
97. Ronco C, Feriani M, Chiaramonte S, et al. Impact of high blood flows on vascular stability in hemodialysis. Nephrol Dial Transpl 1990: Suppl 5, 1: 109-14.
98. Kjellstrand C, Ulan R, Odar-Cederlof I, Ericsson F, Skroder R, Jacobson S. All derived Kt/V overestimate and increasingly deviate from the true Kt/V as dialysis speed is increased and dialysis time shortened. J Am Soc Nephrol 1991; 2: 332-7.
99. Sargent JA. Shortfalls in the delivery of dialysis. Am J Kidney Dis 1990; 15: 500-10.
100. Gotch FA, Yarian S, Keen M. A kinetic survey of US hemodialysis prescriptions. Am J Kidney Dis 1990; 15: 511-5.
101. Le Febre JM, Spanner E, Heidenheim AL, Lindsy RM. kt/V patients do not get what the physician prescribes. ASAIO Trans 1991; 37: M132-3.
102. Delmez JA, Windus DW, The St. Louis Nephrology Study Group. Hemodialysis prescription and delivery in a metropolitan community. Kidney Int 1992; 41: 1023-8.
103. Depner T, Rizwan S, Cheer A, Wagner J. Peripheral urea disequilibrium during hemodialysis is temperature-dependent. J Am Soc Nephrol 1991; 2: 321-5.
104. Ronco C. Dialysis delivery vs. dialysis prescription. Int J Artif Organs 1993; 16: 628-35.
105. Ronco C, Conz P, Bosch JP, Lew S, La Greca G. Assesment of adequacy in peritoneal dialysis. Advances in Renal Replacement Therapy 1994; 1: 15-23.
106. Ronco C, Conz P, Agostini F, Bosch JP, Lew S, La Greca G. The concept of adequacy in peritoneal dialysis. Perit Dial Intern 1994; 14 (Suppl 3): S93-8.
107. Ronco C, Bosch JP, Lew S, et al. Adequacy of continuous ambulatory peritoneal dialysis. Comparison with other dialysis techniques. Kidney Int (in press).
108. Depner TA, Rizwan S, Cheer AY, Wagner J, Eder LA. High venous urea concentration in the opposite arm: a consequence of hemodialysis-induced compartment disequilibruim. J Am Soc Artif Intern Organs 1991; 37: 141-3.
109. Schneditz D, Kaufman AM, Polaschegg HD, Levin NW, Dangirdas JT. Cardiopulmonary recirculation during hemodialysis. Kidney Int 1992; 42: 1450-6.
110. Clark WR, Mueller BA, Alaka KJ, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994; 4: 1413-20.
111. Keshaviah P, Nolph K, Van Stone J. The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Perit Dial Int 1989; 9: 257-60.
112. Frankenfield DC, Reynolds HN, Wiles CE, Badellino MM, Siegel JN. Urea removal during continuous hemofiltration. Crit Care Med 1994; 22: 407-12.
113. Bellomo R, Martin H, Parkin G, Love J, Keazley Y, Boyce N. Continuous arteriovenous haemodiafiltration in the critically ill: influence on major nutrient balances. Intensive Care Med 1991; 17: 399-402.
114. Bellomo R, Seacombe J, Daskalakis M, et al. A prospective comparative study of moderate versus high protein intake for critically ill patients with acute renal failure. Proc Aust NZ Intens Care Society, Scientific meeting (Sydney) (Abstract) 1994, 91.
115. Bellomo R, Mansfield D, Rumble S, Shapiro J, Parkin G, Boyce N. A comparison of conventional dialytic therapy and acute continuous hemodiafiltration in the management of acute renal failure in the critically ill. Ren Fail 1993; 15: 595-602.
116. Bellomo R, Mansfield D, Rumble S, Shapiro J, Parkin G, Boyce N. Acute renal failure in critical illness. Conventional dialysis versus acute continuous hemodiafiltration. ASAIO J 1992; 38: M654-7.
117. Rosa AA, Shideman J, Kjellstrand CM. Dialysis symptoms and stabilization in long-term dialysis, practical application of the CUSUM plot. Arch Intern Med 1980; 140: 804-10.
118. Nies AS, Robertson D, Stone WJ. Hemodialysis hypotension is not the result of uremic peripheral autonomic neuropathy. J Lab Clin Med 1979; 94: 395-401.
119. Kjellstrand CM, Rosa AA, Shideman JR. Hypotension during dialysis: osmolality fall is an important pathogenetic factor. ASAIO J 1980; 3: 11-8.
120. Hakim R, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331: 1338-42.
121. Ogden DAA. A double blind crossover comparison of high and low sodium dialysis. Proc Clin Dial Transplant Forum 1978; 8: 157-61.
122. Leski M, Niethammer T, Wyss T. Glucose enriched dialysate and tolerance to maintenance hemodialysis. Nephron 1979; 24: 271-6.
123. Lauer A, Saccaggi A, Ronco C, Belledonne M, Gladman S, Bosch J. Continuous arteriovenous hemofiltration in the critically ill patient. Ann Intern Med 1983; 99: 455-60.
124. Canaud B, Cristol JP, Klouche K, et al. Slow continuous Ultrafiltration: a means of unmasking myocardial functional reserve in end-stage cardiac disease. Contrib Nephrol 1991; 93: 79-85.
125. Kruger I, Jacobi C, Landwehr P. Effects of continuous venovenous hemofiltration on pulmonary function and hemodynamics in postoperative septic multiorgan failure. Contrib Nephrol 1995; 116: 108-11.
126. Keller E, Reetze-Bonorden P, Lucking HP, Böhler J, Schollmeyer P. Continuous arteriovenous hemodialysis: experience in twenty-six intensive care patients. Contrib Nephrol 1991; 93: 47-50.
127. Laggner AN, Druml W, Lenz K, Schneeweiss B, Grimm G. Influence of ultrafiltration/hemofiltration on extravascular lung water. Contrib Nephrol 1991; 93: 65-70.
128. Alarabi AA, Wikstrom B, Danielson BG. Continuous arteriovenous hemodialysis and hemofiltration in acute renal failure: comparison of uremic control. Contrib Nephrol 1991; 93: 61-4.
129. Bandouin SV, Wiggins J, Keogh BF, Morgan CJ, Evans T. Continuous veno-venous haemofiltration following cardio-pulmonary bypass. Intensive Care Med 1993; 19: 290-3.
130. Coraim FJ, Coraim HP, Ebermann R, Stellwag FM. Acute respiratory failure after cardiac surgery: clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 1986; 14: 714-8.
131. Henrich WL. Arteriovenous or venovenous continuous therapies are not surperior to standard hemodialysis in all patients with acute renal failure. Seminars Dial 1993; 6: 174-6.
132. Henrich WL, Woodard TD, Me Paul JJ. The chronic efficacy and safety of high dialysate: double crossover study. Am J Kidney Dis 1982; 2: 349-53.
133. Velez RL, Woodard TD, Henrich WL. Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction. Kidney Int 1984; 26: 59-65.
134. Sherman RA, Rubin MP, Cooly RP, Eisinger RP. Amelioration of hemodialysis-associated hypotension by the use of cool dialysate. Am J Kidney Dis 1985; 5: 124-7.
135. Agarwal R, Jost C, Khair-el-din T, Victor R, Grayburn P, Henrich WL. 35° C dialysis increases peripheral resistance and improves hemodynamic stability in patients. J Am Soc Nephrol 1992; 3: 351.
136. Schulman G, Fogo A, Gung A, Badr K, Hakim R. Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 1991; 40: 1069-74.
137. Hakim R, Wingard RL, Lawrence P, Parker A, Schulman G. Use of biocompatible membranes improves outcome and recovery from acute renal failure. J Am Soc Nephrol 1992; 3: 367.
138. Hakim R. Clinical implications of hemodialysis membranes biocompatibility. Kidney Int 1993; 44: 484-94.
139. Schiffl H, Lang SM, Koenig A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344: 570-2.
140. Guitierrez A, Alvestrand A, Wahren J, Bergstrom J. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990; 38: 487-94.
141. Bouffard Y, Viale JP, Annat G, Delafosse B, Guillanne G, Motin J. Energy expenditure in the acute renal failure patient mechanically ventilated. Intensive Care Med 1987; 13: 401-4.
142. Elwyn DH. Nutritional requirements of stressed patients. Text book of critical care 2nd edition. (Shoemaker et al eds) WB Saunders Phillidelphia 1989.
143. Cerra FB. Hypermetabolism, organ failure and metabolic support. Surgery 1987; 101: 1-6.
144. Jeejeebhoy KN. Nutrition in critical illness. In: Civetta JM, Taylor RW, Kirby RR, eds. Crit Care, 2nd ed. JB Lippinott Co. Philadelphia 1992; 1093-117.
145. Berger R, Adams L. Nutritional support in the critical care setting. Chest 1989; 96: 139-50.
146. Daly JM, Reynold J, Sigal RK, Shou J, Liberman MD. Effects of dietary protein and amino acids on immune function. Crit Care Med 1990; 18: S86-93.
147. Deitch EA, Dazhong X, Qi L, Specian RD, Berg RD. Protein malnutrition alone and in combination with endotoxin impairs systemic and gut-associated immunity. JPEN 1992; 16: 25-31.
148. Toback FG, Dadd RC, Maier ER, Havener LJ. Amino acid administration enhances renal protein metabolism after acute tubular necrosis. Nephron 1983; 33: 238-43.
149. Garza-Quintero R, Ortega-Lopez J, Stein JH, van Katachalam MA. Alanine protects rabbit proximal tubules against anoxic injury in vitro. Am J Physiol 1987; 258: F1075-83.
150. Kierdorf H, Kindler J, Sieberth HG. Nitrogen balance in patients with acute renal failure treated by continuous haemofiltration. Nephrol Dial Transplant 1986; 1: 72-7.
151. Kierdorf H. Continuous versus intermittent treatment: clinical results in acute renal failure. Contrib Nephrol 1991; 93: 1-12.
152. Weissman C, Heyman AI. Nutritional care of the critically ill patient with respiratory failure. Crit Care Clin 1987; 3: 185-203.
153. Pingleton SK, Harmon GS. Nutritional management in acute respiratory failure. JAMA 1987; 257: 3094-9.
154. Toback FG. Amino acid enhancement of renal regeneration after acute tubular necrosis. Kidney Int 1977; 12: 193-8.
155. La Greca G, Biasioli S, Chiaramonte S, et al. Studies on brain density in hemodialysis and peritoneal dialysis. Nephron 1982; 31: 146-50.
156. La Greca G, Dettori P, Biasioli S, et al. Brain density studies during dialysis. Lancet 1980; 2: 582.
157. Winney RJ, Kean DM, Best JJK, Smith MA. Changes in brain water with haemodialysis. Lancet 1986; 2: 1107-8.
158. Kishimoto T, Yamagami S, Tanaka H, et al. Superiority of haemofiltration to haemodialysis for treatment of chronic renal failure: Comparative studies between haemofiltration and haemodialysis on dialysis disequilibrium syndrome. J Artif Organs 1980; 4: 86-93.
159. Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int 1993; 43 (Suppl 41): S245-51.
160. Davenport A, Will EJ, Davison AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21: 328-38.
161. Davenport A, Will EJ, Davison AM, et al. Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy. Nephron 1989; 53: 142-6.
162. Davenport A, Will EJ, Davison AM, et al. Changes in intracranial pressure during machine and continuous haemofiltration. Int J Artif Organs 1989; 12: 439-44.
163. Davenport A, Finn R, Goldsmith HJ. Management of patients with renal failure complicated by cerebral oedema. Blood Purif 1989; 7: 203-9.
164. Aneff AI. Dialysis disequilibrium syndrome: Current concepts on pathogenesis and prevention. Kidney Int 1994; 45: 629-35.
165. Matsubara S, Okabe K, Ouchi K, et al. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 1990; 18: 1331-6.
166. Ayres SM. SCCM's New Horizons Conference on sepsis and septic shock. Crit Care Med 1985; 13: 864-6.
167. Balk RA, Bone RC. The septic syndrome: definitions and clinical implication. Crit Care Clin 1989; 5: 1-8.
168. Fisher CJ, Opal SM, Dhainaut J-F and the CB 0006 Sepsis Syndrome Study Group. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 1993; 21: 318-27.
169. Marshall JC. Infection and the host septic response: implications for clinical trials of mediator antagonism. In: Vincent J-L, ed. 1994 Yearbook of Intensive Care and Emergency Medicine. Springer, Heidelberg 1994; 3-13.
170. Graziani G, Badalamenti S, Bordone G, et al. The renal removal of cytokines in sepsis. Preliminary report. Proc 3rd Int Satel Symposium on ARF, Halkidiki 1993; 660.
171. Bellomo R, Tipping P, Boyce N. Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-6.
172. Braun N, Giolai M, Rosenfeld S, et al. Clearance of interleukin 6 during continuous veno-venous hemofiltration in patients with septic shock. A prospective controlled study. J Am Soc Nephrol 1993; 4: 336 (abstract).
173. Huffman JN, Faist E, Deppisch R, Inthorn D. Hemofiltration in human sepsis: elimination of immuno modulartory factors. Intensive Care Med 1994; 20 (Suppl. 2): S12 (Abstract).
174. Dinarello CA. Cytokines and biocompatibility. Blood Purif 1990; 8: 208-13.
175. Arnout MA, Hakim RM, Todd RF, Dana N, Colten HR. Increased expression of an adhesion promoting glycoprotein in the granulocytopenia of hemodiaysis. N Engl J Med 1985; 312: 457-62.
176. Himmelfarb J, Lazarus M, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991; 3: 271-6.
177. Luger A, Kovarik J, Stummvoll HK, Urbanska A, Luger T. Blood membrane interaction in hemodialys leads to increased cytokine production. Kidney Int 1987; 32: 84-8.
178. Strasser T, Schiffl H. Generation of leukoriene B 4 by hemodialyser membranes: a novel index of biocompatibility. Klin Wochen Sehr 1991; 69: 808-12.
179. Hakim RM, Schafer IA. Hemodialysis-associated platelet activation and thrombo-cytopenia. Am J Med 1985; 78: 575-80.
180. Gotloib L, Barzilay E, Shustak A, Wais Z, Jaichenko J, Lev A. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 1986; 13: 123-32.
181. Ossenkoppele GJ, van der Meulen J, Bronsveld W, Thijs LG. Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock. Crti Care Med 1985; 13: 102-4.
182. Gomez A, Wang R, Unruh H, et al. Hemofiltration versus left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73: 671-85.
183. Grootendorst AF, van Bommel EFH, van der Hoven B, van Leengoed LAMG, van Osta ALM. High volume hemofiltration improves right ventricular function in endotoxin induced shock in the pig. Intensive Care Med 1992; 18: 235-40.
184. Grootendorst AF, van Bommel EFH, van Leengoed LAMG, van Zanten ARH, Huipen HJC, Groeneveld ABJ. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993; 8: 161-9.
185. Coraim F, Trubel W, Ebermann R, Wolner E. Elimination of myocardial depressant substances by hemofiltration in patients with cardiogenic shock. Circ Shock 1991; 34: 117 (abstract).
186. Steiner B, Pfenninger E, Gruenert A, Schmitz JE, Deller A, Kocher F. The consequences of continuous hemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model, intensive Care Med 1991; 17: 293-8.
187. Lee P, Matson JR, Pryor RW, Hinshaw LBH. Continuous arteriovenous hemofiltration therapy for staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993; 21: 914-24.
188. Barzilay E, Kassler D, Berlot G, Gullo A, Geber D, Ben Zeev I. Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 1993; 17: 634-7.
189. Harris D. Acute renal replacement - which treatment is best. Aust NZ J Med 1990; 20: 197-200.
190. Firth JD. Renal replacement therapy on the intensive care unit. Q J Med 1993; 86: 75-7.